Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

12.07 -0.02 (-0.17%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amarin Corporation plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 04, 2023

Via Benzinga

New REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline

November 12, 2023

From Amarin Corporation plc

Via GlobeNewswire

Amarin Plc (AMRN) Q3 2023 Earnings Call Transcript ↗

November 01, 2023

AMRN earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Amarin Reports Third Quarter 2023 Financial Results

November 01, 2023

From Amarin Corporation plc

Via GlobeNewswire

Why Amarin Stock Is Sinking Today ↗

July 19, 2023

The drugmaker announced a major corporate reorganization and a new CEO.

Via The Motley Fool

Amarin Appoints Jonathan Provoost Executive Vice President, Chief Legal & Compliance Officer

October 31, 2023

From Amarin Corporation plc

Via GlobeNewswire

Latest Research Evaluating VASCEPA®/VAZKEPA® (icosapent ethyl) and Subgroups from the REDUCE-IT Landmark Outcomes Trial to be Presented at the American Heart Association (AHA) Scientific Sessions 2023

October 26, 2023

-- Additional Mechanistic Data on Eicosapentaenoic Acid (EPA) and Real-World Characteristics of Patients with Diabetes on IPE Also Featured at the Meeting --

From Amarin Corporation plc

Via GlobeNewswire

Alphabet To Rally Over 33%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

October 25, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

Amarin to Report Third Quarter 2023 Financial Results and Host Conference Call on November 1, 2023

October 19, 2023

From Amarin Corporation plc

Via GlobeNewswire

Amarin to Present at the 2023 Cantor Global Healthcare Conference

September 12, 2023

From Amarin Corporation plc

Via GlobeNewswire

Around $15M Bet On Taysha Gene Therapies? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

August 17, 2023

The Dow Jones closed lower by around 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Trade Desk, Plug Power, TaskUs And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

August 10, 2023

U.S. stock futures traded higher this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy

August 09, 2023

From Amarin Corporation plc

Via GlobeNewswire

Amarin And Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel

August 08, 2023

From Amarin Corporation plc

Via GlobeNewswire

Scottish Medicines Consortium Accepts VAZKEPA® (icosapent ethyl) to Help Reduce Cardiovascular Risk for Patients in Scotland(1)

August 07, 2023

From Amarin Corporation plc

Via GlobeNewswire

Amarin Reports Second Quarter 2023 Financial Results

August 02, 2023

From Amarin Corporation plc

Via GlobeNewswire

Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea

July 31, 2023

Collaboration Broadens Reach of VAZKEPA to Additional Ten Countries Leveraging Lotus’ Established Commercial and Marketing Expertise in the Region

From Amarin Corporation plc

Via GlobeNewswire

Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress

July 26, 2023

From Amarin Corporation plc

Via GlobeNewswire

Amarin Receives Positive Recommendation from Spanish Drug Pricing Committee for National Reimbursement of VAZKEPA® (icosapent ethyl) in Spain

July 25, 2023

From Amarin Corporation plc

Via GlobeNewswire

Amarin Board of Directors Announces Executive Compensation Program for New President and CEO Patrick Holt

July 20, 2023

From Amarin Corporation plc

Via GlobeNewswire

Nasdaq Moves Lower; US Crude Oil Inventories Decline Less Than Projected ↗

July 19, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.31% to 35,058.78 while the NASDAQ fell 0.21% to 14,323.99. The S&P 500, also...

Via Benzinga

Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 19, 2023

Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 19, 2023

Via Benzinga

Crude Oil Up 1%; M&T Bank Posts Upbeat Q2 Results ↗

July 19, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.5% on Wednesday. The Dow traded up 0.53% to 35,137.16 while the NASDAQ rose 0.48% to 14,422.74. The S&P 500,...

Via Benzinga

Why Are Amarin Shares Plunging Today? ↗

July 19, 2023

Amarin Corporation plc (NASDAQ: AMRN) shares are down after the company on Tuesday announced that it was restructuring in an effort to reduce operating costs by approximately

Via Benzinga

Dow Rises Over 100 Points; Goldman Sachs Earnings Miss Estimates ↗

July 19, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.37% to 35,082.94 while the NASDAQ rose...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 19, 2023

Via Benzinga

Why bluebird bio Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket ↗

July 19, 2023

Gainers 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) shares surged 23.6% to $2.99 in pre-market trading after dipping 21% on Tuesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 19, 2023

It's time for another dive into the biggest pre-market stock movers as we check out all of the latest news for Wednesday!

Via InvestorPlace

Omnicom, Interactive Brokers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

July 19, 2023

U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.